Products
Proteins and Peptides
Proteins and peptidesAccessory Reagents & Controls
Accessory reagents & controlsBiochemicals
BiochemicalsFeatured product
Step up your high-throughput screening with our 384-well SimpleStep ELISA kits.
Learn more about all our product ranges with our product overviews.
Resources
Featured events
Make new connections at our global events.
Support
Our programs
New Lab Program
Get a head start with our exclusive new lab discount. Enjoy 20% off and free shipping for three months.
New Biotech Program
Just starting out? Get 15% off and free shipping to your lab for six months.
Product promise
Peace of mind that all products perform as stated.
Product reviews
Leave reviews, get rewarded and help your community.
Trial program
Try untested species and applications to earn money off your next order.
Epithelial-mesenchymal transition (EMT) markers
Epithelial-mesenchymal transition (EMT) is a critical process in cancer cell metastasis, during which epithelial cells acquire mesenchymal characteristics, including enhanced cell motility and migration. EMT is characterized by a loss of epithelial cell markers, such as cytokeratins and E-cadherin, followed by an upregulation in the expression of mesenchymal cell markers, such as N-cadherin, vimentin, and fibronectin.
These changes in epithelial and mesenchymal cell marker expression lead to a reduction in adhesion between the transitioning cell and adjacent epithelial cells and an increase in the secretion of enzymes that degrade the extracellular matrix. Collectively, this results in epithelial cells losing apical-basal cell polarity, reorganizing their cytoskeleton, and reprogramming gene expression, which allows the development of an invasive phenotype in cancer metastasis.
E-Cadherin
Decreased E-cadherin expression is a fundamental event in EMT and cancer metastasis and has emerged as a molecular hallmark of carcinoma EMT.
Human pluripotent stem cells stained with anti-E-cadherin (ab40772).
We recommend
- We recommend Recombinant Anti-E Cadherin antibody [EP700Y] (ab40772)
- Browse all E-cadherin antibodies
References
N-cadherin
The loss of E-cadherin is typically associated with a gain of expression of the mesenchymal marker, N-cadherin, in many cancer types. It is thought to be necessary for tumor cells to gain invasive properties.
The loss of E-cadherin is typically associated with a gain of expression of the mesenchymal marker, N-cadherin, in many cancer types. It is thought to be necessary for tumor cells to gain invasive properties.
We recommend
References
Vimentin
Overexpression of vimentin is correlated with increased invasiveness and metastasis of several cancers.
Immunohistochemistry (formalin/PFA-fixed paraffin-embedded sections) of human breast adenocarcinoma tissue stained using Recombinant Anti-Vimentin antibody [EPR3776] (ab92547).
We recommend
References
SNAIL
SNAI1, SLUG, ZEB1, ZEB2
The change in the epithelial and mesenchymal gene expression that occurs during EMT is regulated by multiple transcription factor families, including SNAI1/Snail, ZEB1/ZEB2, and basic helix-loop-helix transcription factors (bHLH).
Immunohistochemistry (formalin/PFA-fixed paraffin-embedded sections) of human colon carcinoma tissue stained with Anti-SNAIL + SLUG antibody (ab180714).
We recommend
- We recommend Anti-SNAIL + SLUG antibody (ab180714)
- Browse all SNAIL and SLUG antibodies
- Browse all ZEB1/AREB6 antibodies
- Browse all ZEB2/SIP1 antibodies
References
References
E-Cadherin
Wells, A.,, et al. Clin & Exper Metastasis 25 (6),621–628 (2008)
N-cadherin
Jia, W.,, et al. Anticancer Res. 35 (5),2635-2643 (2015)
Vimentin
Vergara, D., et al EuPA Open Proteomics 10 ,31-41 (2016)
SNAIL
Lamouille, S.,, Xu, J.,, & Derynck, R. Nature Rev: Mol Cell Biol. 15 (3),178–196 (2014)